Month: July 2021

Ipsen Strengthens Its Preclinical Oncology Pipeline With Exclusive Global Collaboration With BAKX Therapeutics Inc. For BKX-001, Targeting The Apoptosis Pathway

PARIS–(COMMERCIAL THREAD) – Regulatory news: Disclaimer: intended for international media and investors only Ipsen (Euronext: IPN; ADR: IPSEY) and BAKX Therapeutics Inc. have signed an exclusive global collaboration agreement for the research, development, manufacture and commercialization of BKX-001 as a potential treatment for leukemia, lymphoma and solid tumors. Apoptosis is the natural process of programmed […]

Back To Top